Back to News
Market Impact: 0.15
Enanta Pharmaceuticals, Inc. Announces Planned Retirement of CEO Jay R. Luly, Ph.D. by February 1, 2027
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Enanta Pharmaceuticals said CEO and President Jay R. Luly, Ph.D., 70, intends to retire by February 1, 2027, after 23 years leading the company. Enanta expects to enter into an agreement with him; the available article text provides no successor or further transition details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- FedEx beats expectations, raises outlook in first report since calendar adjustment
- Warsh says politics played no role in Fed’s rate decision by group he is ’honored’ to lead
- Bausch Health raises 2026 outlook as third-quarter adjusted earnings surge 53%
- Tencent’s Cloud Boss Plays Long Game to Patch ‘Leaky’ AI Ship
- Microsoft reveals strong cloud growth amid financial reporting overhaul
- ECB to hold rates as investors focus on French bonds, Lagarde’s future